Cardiff Oncology Inc (CRDF)
$0.89 -2.46% Close Oct 30, 2026 Live
Cardiff Oncology stock today
Cardiff Oncology closed at $0.89 on October 30, 2026, down 2.46% on the day. Over the past year it returned -60.1% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $61.0 million.
$1.00$2.00$3.00
NovJan 2026MarMayJulSep
| Period | CRDF | S&P 500 (SPY) |
|---|---|---|
| 1 month | -26.5% | -0.9% |
| 3 months | +4.5% | +2.1% |
| Year to date | -68.3% | +11.7% |
| 1 year | -60.1% | +12.4% |
| 3 years | -19.9% | +88.5% |
| 5 years | -84.8% | +76.0% |
Key statistics
- Market value
- $61.0M
- Price / sales
- 120.1
- 52-week range
- $0.80 to $3.21
- Next report
- Nov 12, 2026 (estimated)
About Cardiff Oncology
Develops oncology therapeutics targeting specific cancer pathways and mutations.
Sector: Health Care
More on Cardiff Oncology
- Financials: revenue, earnings and segmentsRevenue -13% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $3.25 today
No forecast, no recommendation. This page describes Cardiff Oncology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.